Janssen Oncology Newsroom
Welcome to the Janssen Oncology Newsroom!
At the Janssen Pharmaceutical Companies of Johnson & Johnson, our commitment to patients, caregivers, and clinicians goes beyond our individual treatments. Our goal is ambitious: we are determined to eliminate cancer. Through our tireless work to advance scientific innovation, address unmet medical needs and improve outcomes for patients, we believe it’s possible.
We invite you to explore the pages below to learn more about the innovation we are presenting at key scientific congresses. Here, we feature presentations from our oncology portfolio and pipeline, highlighting important efforts to advance science and improve outcomes across multiple cancer types with significant unmet need. We are focused on transforming care and delivering innovative therapies that help patients live longer and bring us closer to our goal of delivering cures.
Thank you for visiting, and please continue to check back as we update this site with the latest news from Janssen Oncology.
Peter Lebowitz, M.D., Ph.D.
Global Therapeutic Area Head, Oncology
Janssen Research & Development, LLC.